4

Changes in Ownership

Denali Therapeutics Inc. Filed 2017-12-14 Acc 0000899243-17-028694

10% owner bought 275,000 shares at $18.00 ($4,950,000)

10% owner acquired 19,986,798 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider	Date	Transaction	Shares	Price	Value	Owned after	D/I
BRATTON DOUGLAS K 10% owner	2017-12-12	Conversion	+14,499,999			14,812,499	I
BRATTON DOUGLAS K 10% owner	2017-12-12	Conversion	+2,500,000			17,312,499	I
BRATTON DOUGLAS K 10% owner	2017-12-12	Conversion	+1,875,000			19,187,499	I
BRATTON DOUGLAS K 10% owner	2017-12-12	Conversion	+743,599			743,599	I
BRATTON DOUGLAS K 10% owner	2017-12-12	Conversion	+128,200			871,799	I
BRATTON DOUGLAS K 10% owner	2017-12-12	Conversion	+240,000			1,111,799	I
BRATTON DOUGLAS K 10% owner	2017-12-12	Purchase	+275,000	$18.00	$4,950,000	19,462,499	I
Derivatives
BRATTON DOUGLAS K 10% owner	2017-12-12	Conversion · Series A-1 Convertible Preferred Stock	−14,499,999			0	I
BRATTON DOUGLAS K 10% owner	2017-12-12	Conversion · Series A-2 Convertible Preferred Stock	−2,500,000			0	I
BRATTON DOUGLAS K 10% owner	2017-12-12	Conversion · Series B-1 Convertible Preferred Stock	−1,875,000			0	I
BRATTON DOUGLAS K 10% owner	2017-12-12	Conversion · Series A-1 Convertible Preferred Stock	−743,599			0	I
BRATTON DOUGLAS K 10% owner	2017-12-12	Conversion · Series A-2 Convertible Preferred Stock	−128,200			0	I
BRATTON DOUGLAS K 10% owner	2017-12-12	Conversion · Series B-1 Convertible Preferred Stock	−240,000			0	I
Open-market purchases · 275,000 sh · avg $18.00 · $4,950,000